0001178913-18-001601.txt : 20180510 0001178913-18-001601.hdr.sgml : 20180510 20180510173419 ACCESSION NUMBER: 0001178913-18-001601 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180508 FILED AS OF DATE: 20180510 DATE AS OF CHANGE: 20180510 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: RIGEL DARRELL S CENTRAL INDEX KEY: 0001237422 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36621 FILM NUMBER: 18824226 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Foamix Pharmaceuticals Ltd. CENTRAL INDEX KEY: 0001606645 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2 HOLZMAN ST. STREET 2: WEIZMANN SCIENCE PARK CITY: REHOVOT STATE: L3 ZIP: 76704 BUSINESS PHONE: 97289316233 MAIL ADDRESS: STREET 1: 2 HOLZMAN ST. STREET 2: WEIZMANN SCIENCE PARK CITY: REHOVOT STATE: L3 ZIP: 76704 FORMER COMPANY: FORMER CONFORMED NAME: Foamix Ltd. DATE OF NAME CHANGE: 20140428 4 1 zk1821662.xml OWNERSHIP DOCUMENT X0306 4 2018-05-08 0 0001606645 Foamix Pharmaceuticals Ltd. FOMX 0001237422 RIGEL DARRELL S C/O FOAMIX PHARMACEUTICALS LTD. 2 HOLTZMAN STREET REHOVOT L3 7670402 ISRAEL 1 0 0 0 Options 5.06 2018-05-08 4 A 0 24947 0 A 2028-05-08 Ordinary Shares 24947 24947 D Each option represents a contingent right to purchase one ordinary share of the issuer. The ordinary shares underlying these options vest over a 12 month period, in equal, quarterly installments, ending May 8, 2019. /s/ Ilan Hadar as attorney-in-fact for Darrell Rigel 2018-05-10